Endocrinology

Kalantar-Zadeh K, Friedman TC, Jafari G, Ghaffari A, Khine A, Nicholas SB, Rhee CM, Dhamija R, Raff EA. Population health management of diabetic kidney disease[...]

Troia A, Harvey S, Wu A, Kiparizoska S, Weaver A, Oberai R, Melmed GY, Siegel CA, Singh S, Mattar MC. Understanding the Link Between Patient[...]

Wang SY, Stofer R, Wang H, Brent GA, Shi L, Cai Y, Roosan M, Moin T. Bridging Efficacy and Adherence in Glucagon-Like Peptide-1 Receptor Agonist[...]

Scarlett LD, Solorzano W, Khoshbin K, Villanueva GP, Mangual KS, Tavares M, Santana C, Escobar B, Borrell J, Brumley B, Moin T, Everett E. Impact[...]

Chew L, Feng J, Hutchins E, Stein-Merlob AF, Yang EH, Lechner MG, Tsui E. Immune Checkpoint Inhibitor-Associated Uveitis: Predictors and Survival Impact. Ophthalmol Retina. 2025[...]

Duberstein ZT, Murphy H, Wu Q, Meng Y, Wang C, Smith R, Salafia C, Chowdhury SF, Barrett E, Scheible K, Qiu X, O'Connor TG. Do[...]

Malone A, Tibbe TD, Turk N, Duru OK, Wisk LE, Mangione C, Page J, Thomas SC, Vu A, Madievsky R, Chon J, Cheng F, Liu[...]

Ahern S. Allodynia and Dysesthesia Associated With Semaglutide and Tirzepatide. Cureus. 2025 Oct 8;17(10):e94126. doi: 10.7759/cureus.94126. PMID: 41210042; PMCID: PMC12594042.

Hoolachan JM, Balakrishnan R, McCown EM, Merz KE, Zhou C, Bloom-Saldana E, Fueger PT, Hamilton A, Kiperman T, Ma K, Oh E, Jiang L, Pirrotte[...]

LeVee A, Kordic A, Ruel N, Mortimer J, Kang I, McArthur H, Lechner MG, Tsai K. Safety and Clinical Outcomes of Pembrolizumab Standard-Interval Dosing Versus[...]